✦ LIBER ✦

Nonpeptide RGD Antagonists: A Novel Class of Mimetics, the 5,8-Disubstituted 1-Azabicyclo[5.2.0]nonan-2-one Lactam.

✍ Scribed by Erika Bourguet; Jean-Louis Baneres; Joseph Parello; Xavier Lusinchi; Jean-Pierre Girard; Jean-Pierre Vidal

Publisher: John Wiley and Sons
Year: 2003
Weight: 111 KB
Volume: 34
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200331187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Physicochemical and biopharmaceutical ch

Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist

✍ Andrea Cappelli; Valter Travagli; Iacopo Zanardi; Maurizio Anzini; Gianluca Gior 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

The physicochemical and biopharmaceutical properties, such as pK a , crystal habit, water solubility, logD, molecular structure and dynamics, and membrane permeability of CR3124 (endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1Hbenz[e]isoindol-1-one, a novel potent 5-HT 3 receptor antagon

ChemInform Abstract: Ring-Ring Interconv

ChemInform Abstract: Ring-Ring Interconversions. Part 2. Effect of the Substituent on the Rearrangement of 6-Aryl-3-methyl-5-nitrosoimidazo[2,1-b][1,3]thiazoles into 8-Aryl-8-hydroxy-5-methyl-8H-[1,4]thiazino[3,4-c] [1,2,4]oxadiazol-3-ones. A Novel Class of Potential Antitumor Agents.

✍ Roberta Billi; Barbara Cosimelli; Domenico Spinelli; Mirella Rambaldi 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 2 views

Design and Synthesis of 4-Substituted-8-

Design and Synthesis of 4-Substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4,5]decan-1-one as a Novel Class of GlyT1 Inhibitors: Achieving Selectivity Against the μ Opioid and Nociceptin/Orphanin FQ Peptide (NOP) Receptors.

✍ Andrew W. Thomas; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 18 KB 👁 1 views

Acetazolamide opens the muscular K3.0.CO

Acetazolamide opens the muscular K3.0.CO;2-A/asset/equation/tex2gif-inf-1.gif?v=1&t=h5mnxxo1&s=a3036156329ecd7af7add0fbdd623af613d683c8" class="inlineGraphic"> channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis

✍ Domenico Tricarico; Mariagrazia Barbieri; Diana Conte Camerino 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views